Ganglion Cell Complex Evaluation in Exudative Age-Related Macular Degeneration after Repeated Intravitreal Injections of Ranibizumab

Ganglion Cell Complex Evaluation in Exudative Age-Related Macular Degeneration after Repeated Intravitreal Injections of Ranibizumab

Purpose. To detect the effects of intravitreal ranibizumab injections on GCC in patients with wet AMD. Methods. 32 wet AMD eyes were selected and submitted at three ranibizumab injections. RTVue-OCT GCC and MM5 protocol were performed before treatment and twenty days after each injection. Results. A...

Full description

Bibliographic Details
Main Authors:	Andrea Perdicchi, Giacomo Peluso, Daniela Iacovello, Marco Balestrieri, Martina Delle Fave, Solmaz Abdolrahimzadeh, Gian Luca Scuderi, Vito Fenicia, Santi Maria Recupero
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2015/268796

Similar Items

Intravitreal Injection of Dexamethasone Implant and Ranibizumab in Cystoid Macular Edema in the Course of Irvine-Gass Syndrome
by: Vito Fenicia, et al.
Published: (2014-08-01)

Intravitreal Injection of Dexamethasone Implant in Serous Macular Detachment Associated with Waldenström's Disease
by: Vito Fenicia, et al.
Published: (2013-07-01)

Twelve-Month Results of a Single or Multiple Dexamethasone Intravitreal Implant for Macular Edema following Uncomplicated Phacoemulsification
by: Solmaz Abdolrahimzadeh, et al.
Published: (2015-01-01)

Intravitreal Ranibizumab and Laser Photocoagulation in the Management of Idiopathic Juxtafoveolar Retinal Telangiectasia Type 1: A Case Report
by: Angela Ciarnella, et al.
Published: (2012-09-01)

Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
by: Umut Karaca, et al.
Published: (2012-01-01)

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
by: Canan H, et al.
Published: (2014-01-01)

Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab
by: Carlos Menezes, et al.
Published: (2015-06-01)

Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab
by: Daniel Sanju Narayan, et al.
Published: (2015-01-01)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
by: Suzuki H, et al.
Published: (2017-08-01)

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
by: Tomoko Nakamura, et al.
Published: (2012-01-01)

THE MACULAR HOLE AFTER INTRAVITREAL INJECTIONS OF RANIBIZUMAB IN A PATIENT WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION – A CASE STUDY
by: Magdalena Kal, et al.
Published: (2013-11-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
by: Takayama K, et al.
Published: (2012-06-01)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017-03-01)

Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration
by: Nishimura T, et al.
Published: (2012-07-01)

Intravitreal Ranibizumab Therapy in Wet Type Macular Degeneration
by: Hüseyin Dündar, et al.
Published: (2014-10-01)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
by: Kim M, et al.
Published: (2013-11-01)

Management of retinal artery macroaneurysm exudation in Wyburn-Mason syndrome with intravitreal ranibizumab
by: Anmol U Naik, et al.
Published: (2019-01-01)

Tachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration
by: Sibel Doguizi, et al.
Published: (2015-08-01)

Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema
by: Yu-Dong Fu, et al.
Published: (2017-03-01)

INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO MALIGNANT HYPERTENSION
by: Raquel Claro Brito, et al.
Published: (2016-01-01)

Intravitreal injection of Ranibizumab treating noninfectious uveitic macular edema
by: Hong-Bin Xie, et al.
Published: (2018-09-01)

Intravitreal injection of Ranibizumab combined with laser for diabetic macular edema
by: Yan-Xia Huang, et al.
Published: (2018-04-01)

Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats’ Disease
by: Nowara M, et al.
Published: (2021-01-01)

Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
by: Chiung-Yi Chiu, et al.
Published: (2021-01-01)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
by: Ali Demircan, et al.
Published: (2018-01-01)

Glaucoma Management in Carotid Cavernous Fistula
by: Silvia Calafiore, et al.
Published: (2016-06-01)

Efficacy of intravitreal injection of Ranibizumab combined with macular grid photocoagulation for diabetic macular edema
by: Ping-Ping Ma, et al.
Published: (2020-12-01)

Efficacy of intravitreal ranibizumab injection combined with macular grid photocoagulation for diabetic macular edema
by: Hu-Lin Jiang, et al.
Published: (2014-07-01)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
by: Jeon S, et al.
Published: (2014-08-01)

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
by: Mohamed A. Hamid, et al.
Published: (2021-04-01)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
by: Norihiro Shimizu, et al.
Published: (2017-01-01)

Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report
by: Alexandre Augusto Cabral de Mello Ventura, et al.
Published: (2011-08-01)

Efficiency of Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
by: Didem sahin, et al.
Published: (2015-12-01)

Efficacy of intravitreal dexamethasone implant in persistent diabetic macular edema after primary treatment with intravitreal ranibizumab
by: Kübra Özata, et al.
Published: (2019-09-01)

Intravitreal injection of Conbercept in the treatment of exudative age-related macular degeneration
by: Hong-Xia Niu, et al.
Published: (2018-09-01)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
by: Koike N, et al.
Published: (2019-07-01)

Rapid Regression of Exudative Maculopathy in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis Syndrome after Intravitreal Ranibizumab
by: Cristina Marín-Lambíes, et al.
Published: (2012-08-01)

Optical coherence tomography findings in macular hole complicating exudative age-related macular degeneration treated with ranibizumab
by: Rosa Dolz-Marco
Published: (2013-08-01)

Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
by: Tatsuya Yoshitake, et al.
Published: (2019-05-01)